|
HS Code |
481461 |
| Name | N-Acetyl-L-Valine |
| Chemical Formula | C7H13NO3 |
| Molecular Weight | 159.18 g/mol |
| Cas Number | 1592-95-6 |
| Appearance | White to off-white powder |
| Melting Point | 168-172°C |
| Solubility | Soluble in water |
| Optical Rotation | [α]20/D +20° to +24° (c=1, H2O) |
| Ph | 5.0-6.0 (1% in water) |
| Storage Conditions | Store at 2-8°C |
| Purity | ≥98% |
| Synonyms | N-Acetylvaline; Acetyl-L-valine |
As an accredited N-Acetyl-L-Valine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | N-Acetyl-L-Valine is packaged in a 100g sealed amber glass bottle with tamper-evident cap and detailed product labeling. |
| Shipping | **Shipping Description for N-Acetyl-L-Valine:** N-Acetyl-L-Valine is shipped in tightly sealed containers, protected from moisture and light. It is transported at ambient temperature, complying with standard chemical handling regulations. The packaging is secure to prevent leakage and ensure stability during transit. No special hazard classifications apply for shipping this compound. |
| Storage | N-Acetyl-L-Valine should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of moisture. Keep the container tightly closed and store at room temperature, ideally between 2-8°C. Ensure the chemical is kept away from incompatible substances such as strong oxidizing agents. Properly label storage containers and follow all safety and regulatory guidelines. |
Applications of N-Acetyl-L-Valine in Industrial ManufacturingN-Acetyl-L-Valine serves as a specialized intermediate in various high-value industrial segments, meeting stringent quality and safety requirements. As a direct producer, we support downstream partners with consistent specification and traceable quality for their advanced manufacturing operations. 1. Peptide Synthesis for Pharmaceutical IntermediatesThis material acts as a protected amino acid building block during the solid-phase peptide synthesis process, mainly for creating complex active pharmaceutical ingredients. Downstream pharmaceutical companies utilize it for site-specific acylation, ensuring accurate sequence assembly and reducing racemization during elongation. Our facility’s controlled environment maintains high purity levels, matching the needs for injectable and oral peptide APIs. The material’s stability and compatibility streamline purification, yielding reproducible peptide synthesis outcomes and minimized by-products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Nutraceutical Ingredient FormulationN-Acetyl-L-Valine is used in amino acid supplements and advanced nutraceutical blends, where manufacturers require highly bioavailable, stable valine derivatives for capsule and powder formulations. Stringent control over metal contaminants and residual solvents is enforced, especially for supplements distributed in regulated markets. The acetylated form supports better handling and solubility during direct dry blending or premix manufacture, supporting higher shelf life and consistent taste in final products. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Chiral Chemical Synthesis IntermediateChemical manufacturers incorporate N-Acetyl-L-Valine as a chiral auxiliary or starting material to impart stereospecificity in organic synthesis routes such as asymmetric reduction or amide coupling. Its application supports the manufacture of single-enantiomer intermediates under controlled temperature and solvent systems, reducing the need for post-reaction racemate resolution. Producers leverage its predictable reactivity profile to drive up yield and enantiopurity for fine chemicals and chirally pure drugs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Cell Culture Media SupplementationProducers of animal cell culture media and bioprocessing solutions employ this compound as a metabolically stable valine source to optimize growth and viability of mammalian, insect, and hybridoma cell lines. Its acetylated structure helps mitigate spontaneous racemization and unwanted by-product formation during autoclaving and sterile filtration, especially in high-density or perfusion culture protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive N-Acetyl-L-Valine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working on the production line of N-Acetyl-L-Valine brings everyday challenges and rewards. After years of refining processes, certain details about the product stand out to our team, both in the lab and on the shop floor. Each batch is the result of carefully selected raw materials, controlled synthesis, stringent quality checks, and methodical packaging steps. Direct involvement at every stage means we know precisely what goes into the product, and we take responsibility for its reliability. People often ask us about the differences between N-Acetyl-L-Valine and common amino acids in the market. A lot of our customers come with knowledge grounded in experience, but a few details still make large differences downstream.
N-Acetyl-L-Valine stands apart from ordinary valine in several important ways. Through acetylation, we alter the natural amino to a derivative that resists standard metabolic degradation. This means you get tighter control in peptide synthesis and other chemical work compared to using unmodified valine. Many big players in the pharmaceutical and biotech field—some we’ve supplied for years—have grown used to the stability of acetylated amino acids for applications requiring less reactivity under standard conditions. The added acetyl group changes the compound's performance both in the flask and in the finished product. For peptide coupling, we see improved reaction selectivity and cleaner separations during purification. It’s hard to overstate the benefit of fewer byproducts and simpler analytics, especially when scaling up.
Unlike outlets that resell bulk intermediates, we produce our own N-Acetyl-L-Valine through proprietary processes, strictly controlled at each step. Every production lot undergoes analytical checks: HPLC assays for purity, identification by NMR and mass spectrometry, and targeted screening for traces of solvent residue. Moisture levels have to stay below a set threshold. Our staff verify that each drum or bag meets release requirements before a single gram leaves the plant. We keep detailed records and retain samples for long-term traceability—every order ties back to original test data. Over the years, product consistency has become a source of pride for our team, and we’ve had visiting customers confirm this in their own audits. If an order doesn’t meet specs, it doesn’t ship.
Most of the N-Acetyl-L-Valine we produce serves peptide manufacturers and academic labs. It often acts as a blocked N-terminal residue, helping chemists assemble custom peptide chains that don’t degrade or react in unwanted ways during synthesis. By preventing unwanted cyclizations or side reactions, acetylated amino acids contribute to better product yields, something buyers can see in their HPLC traces. We’ve also heard from researchers in enzymology using it as a model substrate to study specificity shifts. The product’s acetyl group introduces a stability that’s not always possible with alanine or leucine analogues. Biotech start-ups exploring new enzyme inhibitors have leaned on our compound for chemoselective modifications, making consistent batch performance critical for reproducibility. As a manufacturer, we put a lot of effort into understanding the demands of these users. Over time, we’ve learned when a process improvement makes a noticeable difference to their work, and we keep those lines of communication open.
The choice of solvents, temperature settings, and raw material sources shapes the finished compound, not just the final purity numbers. Years ago, we discovered shifts in reagent quality could increase isomeric impurity, which would disrupt crystallization and complicate downstream purification. We responded by tightening supplier controls. Regular, direct engagement with upstream partners brought measurable improvements. Workers at the plant noticed fewer reworks; customers began reporting higher reproducibility batch to batch. Small changes in the process, such as refining the acetylation stage and using computational chemistry to advise tweaks, have made our N-Acetyl-L-Valine a benchmark for comparison. This feedback loop—between chemists, process engineers, and external users—drives the final quality.
Our team puts constant effort into preventing cross-contamination and moisture uptake. With N-Acetyl-L-Valine, exposure to humidity can alter bulk properties and lower shelf life, especially for high-purity material destined for peptide synthesis. Employees take practical steps—double-bagging inside moisture barrier film, nitrogen-purged packaging, regular cycle checks during storage. All labeling lists production date and traceability code. Properly packaged, the material retains full performance for years under dry, cool conditions. Large orders for contract manufacturers receive sealed drums; research users often need smaller aliquots, which our operations group prepares in dedicated packing zones. This approach reduces the risk of handling errors. For every lot, our internal QA team walks through cleanroom protocol and storage checklists. We’ve seen how miss-handling can lead to costly rework, and regular training has dropped those events to near zero.
Being the original manufacturer means we stand behind every lot with detailed process records. As the market for peptide precursors grows, so does the risk of substandard batches and mislabeled intermediates. Our field support frequently gets calls from groups who ran into issues with material obtained through loosely tracked channels. Some saw product instability, impurities, or shipment documentation problems. We walk them through side-by-side testing of our N-Acetyl-L-Valine versus alternatives, tracing any subtle differences in analyticals that matter for high-stakes applications. Over the years, our troubleshooting logs show fewer issues for in-house processed compounds compared to goods passed through multiple hands.
Lab automation and digital monitoring drive efficiency, but real experience comes from the team overseeing daily production. Many of our technical staff have years invested in both benchwork and plant operations. Reworking a process by hand, adapting to a sudden supply chain hiccup, or troubleshooting an unexpected analytic result—these require judgment and skill developed over time. Our technical lead once caught a subtle shift in melting point during release testing; further investigation traced it to a minor raw material impurity which, left unchecked, would have gone unnoticed in high-volume production. As outside requests for custom modifications grow, this embedded knowledge supports flexible small-lot manufacturing, which is impossible to replicate with generic or brokered product.
Customers often compare N-Acetyl-L-Valine by appearance, price, or test specs, but we’ve learned tests only tell half the story. Trace impurities invisible to simple HPLC or mass screens can disrupt scale-up in peptide plants—yield drops, extra purification steps, even off-target biological signatures in downstream testing. Misidentified optical isomers present a separate challenge, particularly for groups using the compound in pharmaceutical leads. We minimize this risk through specific trace analytics and finger-printing of every lot. The decision to produce under dedicated conditions eliminates risk from process co-product carryover. For a biotech innovator juggling tight grant timelines, or a contract manufacturer needing on-time delivery, these differences keep projects on track.
Direct customer feedback leads to our best improvements. Years ago, new feedback from a late-stage clinical client prompted us to re-examine residual solvent levels. Instead of treating their comment as an isolated request, we expanded our analytical program to catch more volatiles. Soon after, other customers noticed the product processed even more predictably. More recently, researchers working on solid-phase synthesis reached out about how trace heavy metal content can produce side reactions in peptide coupling. Their feedback prompted us to adapt a chelation-based clean-up step. Now, every batch that leaves our facility carries updated analytic proof. These aren’t just compliance boxes to tick—they answer real user concerns for reproducible results, batch to batch, order to order.
Lab scientists working with N-Acetyl-L-Valine see the practical impact right away. Its physical form remains easy to weigh and dissolve—a convenience appreciated by those who spend hours at the bench. Our in-process staff know that consistency in flow properties allows straightforward handling. Fast dissolution in standard aqueous buffers means no waiting, even during rapid parallel syntheses. The crystalline structure resists caking, avoiding loss during transfer. In universities, graduate students and postdocs routinely provide feedback about how a clean, single-spot TLC profile and absence of background peaks in NMR save them significant prep time.
Years of keeping our N-Acetyl-L-Valine manufacturing in-house has built trust in research, biotech, and pharma communities. Researchers want to know the origin of every starting material, confident the pathway to the compound is direct and documented. For groups working on IP-sensitive projects, knowledge of a single manufacturing location reduces exposure risk. From our perspective, a transparent, open-door approach—routine audits, open records access, real-time order status—means customers see the steps behind every lot. No guesswork about the product journey. Competitive pricing matters, but being a direct manufacturer gives more control over costs and delivery. Should a batch require certification to additional specs, we can make in-process adjustments or offer extra analytical data. Partners in government labs, institutes, and specialty biotech rest easier knowing the material’s backstory is clear and the manufacturer stands behind it.
A manufacturer’s role doesn’t end with final product release. The supply chain for N-Acetyl-L-Valine starts with reliable sources for L-Valine, acetic anhydride, and process aids. To ensure chemical integrity and avoid supply shocks, we place a high priority on auditing suppliers and verifying documentation at every stage. By taking delivery direct from primary chemical producers—rather than adding layers of traders—we control quality and can act quickly when market volatility threatens a supply chain. During industry shortages, our advance procurement system has prevented common out-of-stock events. Shipping back non-conforming raw materials costs time, but in the larger picture, it pays off in final product consistency. Attention to detail at the sourcing level reaches all the way through to the material our customers receive.
Peptide research continues to drive new therapeutic and diagnostic projects. Modifications at the amino terminus—using compounds like N-Acetyl-L-Valine—are routine strategies for improving stability and function. We have watched the adoption curve for these derivatives grow over the past decade, especially as clinical demands move toward complex, multi-residue peptides. Reliable N-Acetyl-L-Valine supports high-yield syntheses that translate to better preclinical results. With more workflows going to automated peptide synthesizers, a standardized, impurity-free supply makes sequencing easier across a wide range of protocols. We have also seen unique uses: agricultural biotech groups have examined stability effects in crop-protection peptides; materials scientists have explored new biopolymer designs. Expansion into these areas means the need for certified, single-origin product will only grow.
Every production cycle for N-Acetyl-L-Valine brings lessons. Real-world chemistry means not every lot behaves identically. We track every batch for deviations, review analytics and document outcomes. Trends matter: early noticing of a slow drift in water content, or a pattern in minor isomer formation means we troubleshoot before it reaches the customer. A full committee—chemists, process engineers, compliance—reviews any flagged batch. Instead of seeking a bland “within spec” confirmation, each review asks how the batch lines up with historical best performance. Documentation, both digital and paper, stays available for years. Auditors regularly ask for these records, and we provide direct, unfiltered access. We’ve heard from more than one pharma QA officer that these detailed logs simplified their validation cycles.
Daily handling of N-Acetyl-L-Valine at scale involves proactive safety attention. Although the compound itself is stable and demonstrates low acute hazard under controlled factory conditions, our team trains in proper personal protective gear use, containment, and emergency procedure refreshers. Sensitive analytical chemists and production workers take care during sampling and transfer, ensuring no air or moisture ingress. Regular maintenance keeps reactor seals and transfer lines tight, reducing unnecessary exposure. Every kilogram leaving our warehouse reflects not just the effort to meet chemical spec, but hours spent on ensuring a zero-incident workplace. This culture of operational vigilance is an undervalued difference in a manufacturing environment, as even simple lapses ripple into expensive disruptions down the line.
We ship N-Acetyl-L-Valine globally, which brings routine regulatory and logistical challenges. Export to certain countries requires dual-language documentation and specific purity disclosures. Our shipping department coordinates with logistics partners to arrange temperature-stable, shock-protected transit for bulk quantities. Small, research-scale packaging rides in securely sealed, tamper-evident containers, each labeled to match analytical records. We provide complete, batch-matched documentation outlining production date, expiry, and all requested analytic results. With every overseas shipment, our staff pre-check customs paperwork requirements to avoid costly delays or compliance issues at borders. For local deliveries, we offer direct drop-off or customer pickup; these options help our long-term partners hit their project deadlines and cut down on wait times.
As a manufacturer, we field technical, analytical, and regulatory questions every day. Staff scientists answer questions directly—no need for customer service scripts. Questions about unusual analytical findings, process changes, or intended applications reach our technical team right away. Many biotech clients value being able to connect directly with someone who has made, tested, and packed their order rather than a sales office. This culture of direct responsibility has led to strong relationships, continuous business, and shared process improvements that come only from open communication.
The science behind peptides and custom amino acid derivatives keeps evolving, and so do our processes. Product purity, flexibility in scale, and in-depth support remain our top priorities. We continue to invest in advanced analytical methods, remote tracking during production, and new ways to cut waste while producing consistent material. As more research and pharma companies pursue next-generation peptides, N-Acetyl-L-Valine’s role will expand. By remaining independent, transparent, and detail-focused, we will serve partners who rely on real quality and accountability. Our history manufacturing this essential intermediate is a point of pride—and every new batch is a fresh opportunity to deliver the standard our customers expect.